Rapat Pittayanon

Rapat Pittayanon

Auto-generated profile, based on publicly available information

Rapat Pittayanon

Division of Gastroenterology, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Gastroenterology
Verified
Journal Article
Closed access
RPRapat Pittayanon
Rapat Pittayanon
JLJennifer T. Lau
Jennifer T. Lau
YYYuhong Yuan
Yuhong Yuan
GLGrigorios I. Leontiadis
Grigorios I. Leontiadis
FTFrances Tse
Frances Tse
PMPaul Moayyedi
Paul Moayyedi

1 March 2020 in Gastroenterology
Verified
Journal Article
Closed access
RPRapat Pittayanon
Rapat Pittayanon
JLJennifer T. Lau
Jennifer T. Lau
GLGrigorios I. Leontiadis
Grigorios I. Leontiadis
FTFrances Tse
Frances Tse
YYYuhong Yuan
Yuhong Yuan
PMPaul Moayyedi
Paul Moayyedi

27 April 2017 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PDF file
RPR. Pittayanon
R. Pittayanon
RRR. Rerknimitr
R. Rerknimitr
NKN. Klaikaew
N. Klaikaew
ASA. Sanpavat
A. Sanpavat
SCS. Chaithongrat
S. Chaithongrat
ABAlan N. Barkun
Alan N. Barkun

3 June 2023 in Gastroenterology
Verified
Journal Article
Closed access
RPRapat Pittayanon
Rapat Pittayanon
WKWichitra Khongka
Wichitra Khongka
SLSittikorn Linlawan
Sittikorn Linlawan
RTRattikorn Thungsuk
Rattikorn Thungsuk
SASurasak Aumkaew
Surasak Aumkaew
ABAlan Barkun
Alan Barkun

1 February 2022 in Annals of Internal Medicine
Verified
Journal Article
Closed access
JLJames Y.W. Lau
James Y.W. Lau
RPRapat Pittayanon
Rapat Pittayanon
AKAndrew Kwek
Andrew Kwek
Raymond TangRaymond Tang
Raymond Tang
HCHeyson Chan
Heyson Chan
JSJoseph JY Sung
Joseph JY Sung
The effectiveness of the hemostatic powder TC-325 as a single endoscopic treatment for acute nonvariceal upper gastrointestinal bleeding is uncertain. This trial, which was conducted at 3 universit... Visual Hemostatic Powder Versus Standard Treatment for Upper Nonvariceal Lesions. The effectiveness of the hemostatic powder TC-325 as a single endoscopic treatment for acute nonvariceal u... Background: The effectiveness of the hemostatic powder TC-325 as a single endoscopic treatment for acute nonvariceal upper gastrointestinal bleeding is uncertain. Objective: To compare TC-325 with ...

28 October 2022 in Gut
Verified
Journal Article
Open access
PDF file
SCShannon Chan
Shannon Chan
RPRapat Pittayanon
Rapat Pittayanon
HWHsiu-Po Wang
Hsiu-Po Wang
JCJiann-Hwa Chen
Jiann-Hwa Chen
ATAnthony YB Teoh
Anthony YB Teoh
PCPhilip Wai Yan Chiu
Philip Wai Yan Chiu
Introduction Over-the-scope clip (OTSC) has been used recently for primary haemostasis of peptic ulcers. This study aimed to compare the efficacy of OTSC to standard endoscopic therapy in primary treatment of patients with peptic ulcer bleeding that are of size ≥1.5 cm. The target population accounts for only 2.5% of all upper GI bleeders. Methods This was a multicentre international randomised controlled trial from July 2017 to October 2020. All patients with Forest IIa or above peptic ulcers of ≥1.5 cm were included. Primary outcome was 30-day clinical rebleeding. Secondary endpoints include 3-day all-cause mortality, transfusion requirement, hospital stay, technical and clinical success, and further interventions. 100 patients are needed to yield a power of 80% to detect a difference of −0.15 at the 0.05 significance level (alpha) using a two-sided Z-test (pooled). Results 100 patients were recruited. Success in achieving primary haemostasis was achieved in 46/50 (92%) and 48/50 (96%) in the OTSC and conventional arm, respectively. Among patients who had success in primary haemostasis, 2/46 (4.35%) patients in the OTSC arm and 9/48 (18.75%) patients in the conventional arm developed 30-day rebleeding (p=0.03). However, in an intention-to-treat analysis, there was no difference in rebleeding within 30 days (5/50 (10%) OTSC vs 9/50 (18%) standard, p=0.23) or all-cause mortality (2/50 (4%) OTSC vs 4/50 (8%) standard, p=0.68; OR=2.09, 95% CI 0.37 to 11.95). There was also no difference in transfusion requirement, hospital stay, intensive care unit admission and further interventions. Conclusion The routine use of OTSC as primary haemostasis in large bleeding peptic ulcers was not associated with a significant decrease in 30-day rebleeding. Trial registration number NCT03160911.